CEO Reid Robison met with StartUp Health Now to discuss the founding and ongoing development and growth of Tute Genomics. Robison commented that,
“One thing that I really like to emphasize is that, you’ve got to believe 100 percent in your idea or it’s not worth doing…Luckily, it’s a good time to be, not only in digital health in terms of fundraising, but in genomics especially because we are beginning this genome revolution.”
Tute Genomics is helping to shape personalized medicine and transform the future of healthcare. “A big initiative of ours is to integrate with the electronic health records and the healthcare systems to get the genome data at the fingertips of the doctor and the patient, where it’s most useful and actionable, to help guide medical treatment decisions,” said Robison.
To read more of CEO Reid Robison’s vision for the future of medicine with Tute Genomics and their plans to get there, click here to watch and/or read the full interview with Robison.
—-